Our results suggest that the combination of neurofilament light chain, fibroblast growth factor 21 and growth and differentiation factor 15 is useful in the diagnostic evaluation of mitochondrial disease. This evidence concerns the gene NEFL and inborn mitochondrial metabolism disorder.